Success Story: NIW Approved for a Postdoctoral Researcher the field of Advancing Aerodigestive Medicine
Client’s Testimonial:
“My attorney did an excellent job. She was patient and responded to every single question I had during the process. I'll retain the firm for additional processes if needed.”
On January 3rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the field of Aerodigestive Medicine (Approval Notice).
General Field: Aerodigestive Medicine
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Colombia
State of Residence at the Time of Filing: Arizona
Approval Notice Date: January 3rd, 2026
Processing Time: 1 month, 2 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of a postdoctoral researcher whose work advances how clinicians detect, evaluate, and manage gastroesophageal reflux disease (GERD) and related aerodigestive complications. The proposed endeavor focuses on clinical and translational research to improve the accuracy and clinical usefulness of physiologic and noninvasive diagnostic tests for GERD and reflux-related lung injury. At the time of filing, the client was continuing this work through a U.S.-based research appointment aligned with the proposed endeavor.
Research with National Importance
In the petition, we demonstrated substantial merit and national importance by showing how sustainability accounting strengthens environmental accountability and improves how institutions track, evaluate, and respond to climate-related risks. By connecting environmental performance metrics to governance and management decision-making, the client’s work supports clearer reporting, stronger compliance planning, and more informed sustainability outcomes across sectors.
Academic Contributions and Recognition
In the petition, we demonstrated substantial merit and national importance by connecting the endeavor to major U.S. public health needs and healthcare efficiency. GERD is highly prevalent, and reflux can contribute to serious downstream respiratory complications. The client’s research addresses key clinical gaps that directly influence patient outcomes by refining diagnostic precision, improving decision-making around antireflux procedures, and developing earlier, less invasive methods to identify reflux-related lung injury before severe damage occurs. This work supports more evidence-based care and helps reduce unnecessary interventions and avoidable costs.
Academic Contributions and Recognition
The petition highlighted a sustained record of scholarship and independent impact. The client has authored 37 peer-reviewed journal articles (at least 26 as first author), 52 conference proceedings, 3 book chapters (one as first author), and one book, and the record documents 77 citations to date. The petition further emphasized that multiple publications achieved strong citation percentile performance within clinical medicine for their publication periods, supporting the conclusion that peers are actively relying on and building upon the client’s findings. The case also documented at least 17 completed peer reviews for respected journals, reflecting consistent professional trust in the client’s expertise in aerodigestive medicine.
NIW Approval and Outlook
The I-140 NIW petition was filed on December 1st, 2025, and approved on January 3rd, 2026, following an upgrade to premium processing. In the filing, we presented a clear NIW framework showing that the endeavor has substantial merit and national importance, the client is well-positioned to advance it through ongoing U.S.-based research and a documented record of publication impact and peer recognition, and that granting the waiver benefits the United States by enabling continued progress in the field.